ATNM
Price
$1.50
Change
-$0.11 (-6.83%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
46.48M
40 days until earnings call
GBIO
Price
$0.37
Change
-$0.04 (-9.76%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
27.14M
29 days until earnings call
Ad is loading...

ATNM vs GBIO

Header iconATNM vs GBIO Comparison
Open Charts ATNM vs GBIOBanner chart's image
Actinium Pharmaceuticals
Price$1.50
Change-$0.11 (-6.83%)
Volume$4.51K
Capitalization46.48M
Generation Bio
Price$0.37
Change-$0.04 (-9.76%)
Volume$14.79K
Capitalization27.14M
ATNM vs GBIO Comparison Chart
Loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNM vs. GBIO commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNM is a StrongBuy and GBIO is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (ATNM: $1.61 vs. GBIO: $0.41)
Brand notoriety: ATNM and GBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNM: 69% vs. GBIO: 83%
Market capitalization -- ATNM: $46.48M vs. GBIO: $27.14M
ATNM [@Biotechnology] is valued at $46.48M. GBIO’s [@Biotechnology] market capitalization is $27.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNM’s FA Score shows that 0 FA rating(s) are green whileGBIO’s FA Score has 0 green FA rating(s).

  • ATNM’s FA Score: 0 green, 5 red.
  • GBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, ATNM is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNM’s TA Score shows that 5 TA indicator(s) are bullish while GBIO’s TA Score has 5 bullish TA indicator(s).

  • ATNM’s TA Score: 5 bullish, 5 bearish.
  • GBIO’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, GBIO is a better buy in the short-term than ATNM.

Price Growth

ATNM (@Biotechnology) experienced а +8.05% price change this week, while GBIO (@Biotechnology) price change was -18.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.07%. For the same industry, the average monthly price growth was -13.26%, and the average quarterly price growth was -12.25%.

Reported Earning Dates

ATNM is expected to report earnings on May 12, 2025.

GBIO is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-9.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATNM($46.5M) has a higher market cap than GBIO($27.1M). ATNM YTD gains are higher at: 27.778 vs. GBIO (-61.792). ATNM has higher annual earnings (EBITDA): -44.15M vs. GBIO (-74.26M). GBIO has more cash in the bank: 185M vs. ATNM (78.7M). ATNM has less debt than GBIO: ATNM (1.71M) vs GBIO (93.6M). GBIO has higher revenues than ATNM: GBIO (19.9M) vs ATNM (81K).
ATNMGBIOATNM / GBIO
Capitalization46.5M27.1M172%
EBITDA-44.15M-74.26M59%
Gain YTD27.778-61.792-45%
P/E RatioN/AN/A-
Revenue81K19.9M0%
Total Cash78.7M185M43%
Total Debt1.71M93.6M2%
FUNDAMENTALS RATINGS
ATNM: Fundamental Ratings
ATNM
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATNMGBIO
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 6 days ago
73%
Bullish Trend 15 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLM478.130.13
+0.03%
Martin Marietta Materials
CNNE18.33-0.19
-1.03%
Cannae Holdings
HXL54.76-1.55
-2.75%
Hexcel Corp
DDL2.70-0.11
-3.91%
Dingdong (Cayman) Limited
XGN3.59-0.25
-6.51%
Exagen

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with ABOS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
-5.33%
ABOS - GBIO
49%
Loosely correlated
-7.56%
ATNM - GBIO
46%
Loosely correlated
-11.05%
AURA - GBIO
45%
Loosely correlated
-7.57%
ATOS - GBIO
44%
Loosely correlated
-3.35%
FHTX - GBIO
44%
Loosely correlated
+3.69%
More